Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine

Transplantation

Volumn 62, Issue 11, 1996, Pages 1588-1592

  Taler, Sandra J ^a   Textor, Stephen C ^a   Canzanello, Vincent J ^a   Schwartz, Lora ^a   Porayko, Michael ^a   Wiesner, Russell H ^a   Krom, Ruud A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; STEROID THERAPY;

BLOOD PRESSURE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISONE; TACROLIMUS;

EID: 0030448982     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612150-00011     Document Type: Article

References (16)

1. Textor SC, Canzanello VJ, Taler SJ, et al. Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 1994; 69: 1182.
2. Textor SC, Wiesner R, Wilson DJ, et al. Systemic and renal hemodynamic differences between FK506 and cyclosporine A in liver transplant recipients. Transplantation 1993; 55: 1332.
3. Todo S, Fung JJ, Tzakis A, et al. One hundred ten consecutive primary orthotopic liver transplants under FK506 in adults. Transplant Proc 1991; 23: 1397.
4. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423.
5. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK507) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.
6. Krom RAF, Wiesner RH, Rettke SR, et al. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 1989; 64: 84.
7. Porayko MK, Textor SC, Krom RAF, et al. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc 1994; 69: 105.
8. Textor SC, Schwartz L, Canzanello VJ, et al. Resolution of posttransplant hypertension after liver transplantation despite impaired glomerular filtration. J Am Soc Nephrol 1994; 5: 1223.
9. Textor SC, Wilson DJ, Lerman A, et al. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. Transplantation 1992; 54: 74.
10. Whitworth JA. Studies on the mechanisms of glucocorticoid hypertension in humans. Blood Press 1994; 3: 24.
11. Whitworth JA. Mechanisms of glucocorticoid-induced hypertension. Kidney Int 1987; 31: 1213.
12. Pirpiris M, Krishnankutty S, Yeung S, Jennings G, Whitworth JA. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 1992; 19: 567.
13. Sato A, Funder JW, Okubo M, Kubota E, Saruta T. Glucocorticoid-induced hypertension in the elderly; relation to serum calcium and family history of essential hypertension. Am J Hypertens 1995; 8: 823.
14. Canzanello VJ, Textor SC, Taler SJ, et al. Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. J Am Soc Nephrol 1995; 5: 1910.
15. Textor SC, Burnett JC, Romero JC, et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int 1995; 47: 1426.
16. Textor SC, Canzanello VJ, Taler SJ, et al. Activation of the renin-angiotensin system and sustained endothelin release two years after liver transplantation [Abstract]. Circulation 1994; 90: 1-73.